Your browser doesn't support javascript.
loading
APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
Brickman, Adam M; Schupf, Nicole; Manly, Jennifer J; Stern, Yaakov; Luchsinger, José A; Provenzano, Frank A; Narkhede, Atul; Razlighi, Qolamreza; Collins-Praino, Lyndsey; Artero, Sylvaine; Akbaraly, Tasnime N; Ritchie, Karen; Mayeux, Richard; Portet, Florence.
Affiliation
  • Brickman AM; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; G.H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and S
  • Schupf N; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; G.H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Epidemiology, Mailman School of Public
  • Manly JJ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; G.H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and S
  • Stern Y; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; G.H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and S
  • Luchsinger JA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Provenzano FA; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Narkhede A; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Razlighi Q; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Collins-Praino L; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Artero S; Inserm, 1061 Neuropsychiatry, La Colombière Hospital, Montpellier, France; Faculty of Medicine University of Montpellier 1, Montpellier, France.
  • Akbaraly TN; Inserm, 1061 Neuropsychiatry, La Colombière Hospital, Montpellier, France; Faculty of Medicine University of Montpellier 1, Montpellier, France; Department of Epidemiology and Public Health, Faculty of Medicine, Imperial College, University College London, London, UK.
  • Ritchie K; Inserm, 1061 Neuropsychiatry, La Colombière Hospital, Montpellier, France; Faculty of Medicine University of Montpellier 1, Montpellier, France; Department of Epidemiology and Public Health, Faculty of Medicine, Imperial College, University College London, London, UK.
  • Mayeux R; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA; G.H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and S
  • Portet F; Inserm, 1061 Neuropsychiatry, La Colombière Hospital, Montpellier, France; Faculty of Medicine University of Montpellier 1, Montpellier, France.
Alzheimers Dement ; 10(6): 619-29, 2014 Nov.
Article in En | MEDLINE | ID: mdl-25304991
ABSTRACT

BACKGROUND:

We previously demonstrated that parietal lobe white matter hyperintensities (WMH) increase the risk for Alzheimer's disease (AD). Here, we examined whether individuals with apolipoprotein E gene (APOE ε4) have increased parietal WMH volume.

METHODS:

Participants were from the Washington Heights-Inwood Columbia Aging Project (WHICAP; n = 694, 47 with dementia) in northern Manhattan and the Etude Santé Psychologique Prévalence Risques et Traitement study (ESPRIT; n = 539, 8 with dementia) in Montpellier. The association between regional WMH and APOE ε4 was examined separately in each group and then in a combined analysis.

RESULTS:

In WHICAP, ε4 carriers had higher WMH volume particularly in parietal and occipital lobes. In ESPRIT, ε4 carriers had elevated WMH particularly in parietal and temporal lobes. In the combined analysis, ε4 carriers had higher WMH in parietal and occipital lobes. Increased WMH volume was associated with increased frequency of dementia irrespective of APOE ε4 status; those with the ε4 were more likely to have dementia if they also had increased parietal WMH.

CONCLUSIONS:

APOE ε4 is associated with increased parietal lobe WMH.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Parietal Lobe / Apolipoprotein E4 / Alzheimer Disease / White Matter Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Alzheimers Dement Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Parietal Lobe / Apolipoprotein E4 / Alzheimer Disease / White Matter Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Alzheimers Dement Year: 2014 Type: Article